Data gathered: December 26
Alternative Data for Bio-Rad
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 146 | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 628,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 27 | Sign up | Sign up | Sign up |
| Patents | 481 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 36 | Sign up | Sign up | Sign up |
| Facebook Followers | 10,399 | Sign up | Sign up | Sign up |
| Instagram Followers | 13,099 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 976 | Sign up | Sign up | Sign up |
| Twitter Followers | 16,926 | Sign up | Sign up | Sign up |
| Twitter Mentions | 24 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 52 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,832 | Sign up | Sign up | Sign up |
About Bio-Rad
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market.
| Price | $332.00 |
| Target Price | Sign up |
| Volume | 15,640 |
| Market Cap | $9.24B |
| Year Range | $263.97 - $374.28 |
| Dividend Yield | 0% |
| PE Ratio | 31.53 |
| Analyst Rating | 60% buy |
| Industry | Biotechnology |
In the news
 |
Tidal Investments LLC Sells 2,077 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)December 25 - ETF Daily News |
|
Equities Analysts Set Expectations for BIO Q4 EarningsDecember 23 - ETF Daily News |
|
Zacks Research Has Positive Forecast for BIO FY2024 EarningsDecember 21 - ETF Daily News |
|
Wellington Management Group LLP Grows Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)December 18 - ETF Daily News |
|
Quantinno Capital Management LP Acquires New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)December 16 - ETF Daily News |
|
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Fmr LLCDecember 16 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 650M | 500M | 356M | 653M | 879M | 2.010 |
| Q2 '24 | 628M | 483M | 355M | -2.17B | -2.77B | 3.110 |
| Q1 '24 | 600M | 542M | 326M | 384M | 546M | 2.290 |
| Q4 '23 | 681M | 420M | 366M | 350M | 338M | 3.100 |
| Q3 '23 | 621M | 504M | 336M | 106M | 156M | 2.330 |
Insider Transactions View All
| Last Andrew J. filed to sell 7,559 shares at $329.9. September 10 '24 |
| BARRY JAMES filed to sell 147 shares at $330.5. September 4 '24 |
| Crowley Michael filed to sell 6,573 shares at $281.9. June 14 '24 |
| ERNST TIMOTHY S filed to sell 3,397 shares at $330.6. February 29 '24 |
| Crowley Michael filed to sell 6,942 shares at $336. February 28 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Sell | $15K - $50K |
| Lois Frankel Democrat |
Oct 10, 23 | Sell | $1K - $15K |
Read more about Bio-Rad (BIO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bio-Rad?
The Market Cap of Bio-Rad is $9.24B.
What is Bio-Rad's PE Ratio?
As of today, Bio-Rad's PE (Price to Earnings) ratio is 31.53.
What is the current stock price of Bio-Rad?
Currently, the price of one share of Bio-Rad stock is $332.00.
How can I analyze the BIO stock price chart for investment decisions?
The BIO stock price chart above provides a comprehensive visual representation of Bio-Rad's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bio-Rad shares. Our platform offers an up-to-date BIO stock price chart, along with technical data analysis and alternative data insights.
Does BIO offer dividends to its shareholders?
As of our latest update, Bio-Rad (BIO) does not offer dividends to its shareholders. Investors interested in Bio-Rad should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bio-Rad?
Some of the similar stocks of Bio-Rad are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.